Clinical Trial Update: A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack [Phase 3]

View source ↗

Summary

This Phase 3 trial aims to assess whether ziltivekimab reduces atherosclerotic plaque in the coronary arteries of patients who have had a heart attack, compared…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Ziltivekimab

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Myocardial Infarction | Phase 3 | Status: RECRUITING